Cytotoxic agents in the treatment of malignant disease.
D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002699:Chlorambucil / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007414:Intestinal Neoplasms / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D013852:Thiotepa / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D006834:Hydrazines; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate